6:
Prospective study of combination chemotherapy with cyclophosphamide, doxorubicin, and cisplatin for unresectable or metastatic malignant pleural mesothelioma.
Shin DM, Fossella FV, Umsawasdi T, Murphy WK, Chasen MH, Walsh G, Komaki R, McMurtrey MJ, Hong WK.
Cancer. 1995 Dec 1;76(11):2230-6.
PMID: 8635025 [PubMed - indexed for MEDLINE]
Related Articles
9:
Phase II study of a liposome-entrapped cisplatin analog (L-NDDP) administered intrapleurally and pathologic response rates in patients with malignant pleural mesothelioma.
Lu C, Perez-Soler R, Piperdi B, Walsh GL, Swisher SG, Smythe WR, Shin HJ, Ro JY, Feng L, Truong M, Yalamanchili A, Lopez-Berestein G, Hong WK, Khokhar AR, Shin DM.
J Clin Oncol. 2005 May 20;23(15):3495-501.
PMID: 15908659 [PubMed - indexed for MEDLINE]
Related Articles
11:
Palliative intravenous cisplatin treatment for concurrent peritoneal and pleural mesothelioma in a dog.
Seo KW, Choi US, Jung YC, Hong SJ, Byeun YE, Kang MS, Pachrin B, Kim WH, Hwang CY, Kim DY, Youn HY, Lee CW.
J Vet Med Sci. 2007 Feb;69(2):201-4.
PMID: 17339766 [PubMed - indexed for MEDLINE]
Related Articles
12:
Gemcitabine combined with carboplatin in patients with malignant pleural mesothelioma: a multicentric phase II study.
Favaretto AG, Aversa SM, Paccagnella A, Manzini Vde P, Palmisano V, Oniga F, Stefani M, Rea F, Bortolotti L, Loreggian L, Monfardini S.
Cancer. 2003 Jun 1;97(11):2791-7.
PMID: 12767092 [PubMed - indexed for MEDLINE]
Related Articles
20:
Phase II study of pemetrexed in combination with carboplatin in patients with malignant pleural mesothelioma (MPM).
Castagneto B, Botta M, Aitini E, Spigno F, Degiovanni D, Alabiso O, Serra M, Muzio A, Carbone R, Buosi R, Galbusera V, Piccolini E, Giaretto L, Rebella L, Mencoboni M.
Ann Oncol. 2008 Feb;19(2):370-3. Epub 2007 Dec 20.
PMID: 18156144 [PubMed - indexed for MEDLINE]
Related Articles